• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Cynthia Delgado Explains How Patients With Disabilities Experience Kidney Care Differently

Video

Physical disabilities may make it difficult for patients with chronic kidney disease to follow provider recommendations and achieve a good therapeutic alliance, which can lead to increased burden of illness, according to Cynthia Delgado, MD, associate professor of medicine at the San Francisco Veterans Affairs Medical Center and University of California San Francisco Medical Center.

Physical disabilities may make it difficult for patients with chronic kidney disease (CKD) to follow provider recommendations and achieve a good therapeutic alliance, which can lead to increased burden of illness, according to Cynthia Delgado, MD, associate professor of medicine at the San Francisco Veterans Affairs Medical Center and University of California San Francisco Medical Center.

Transcript

How do people with physical disabilities experience kidney care differently?

Well, it really is about the context of the disability itself. I think if patients are experiencing CKD care, similar to someone who doesn’t necessarily have the particular disability that they may have, we may end up putting an additional burden on that individual with regards to simple things like taking medications following nutritional recommendations. If you have issues with your sight or your hearing or other physical disabilities, those simple directions or directives may actually increase the challenges of you achieving a good therapeutic alliance with your provider.

What are the potential consequences of the disparities experienced by people with disabilities?

Well, one of the major potential consequences in my mind is that the patient themselves has an increased burden of essentially doing the things that others may not have that burden of completing. And additionally, that burden may actually translate into other issues and other aspects of the patient’s life, including inability to really function within the confines of their life space.

Related Videos
Shawn Kwatra, MD, dermatologist, John Hopkins University
Dr Laura Ferris Discusses Safety, Efficacy of JNJ-2113 in Patients with Plaque Psoriasis
dr krystyn van vliet
Martin Dahl, PhD, senior vice president, AnaptysBio
Jeff Stark, MD, vice president, head of medical immunology, UCB.
Jonathan Silverberg, MD, PhD, MPH, FAAD, professor of dermatology, director of clinical research and patch testing, George Washington University School of Medicine and Health Sciences
Monica Li, MD, University of British Columbia
Robert Sidbury, MD, MPH, FAAD, professor of pediatrics, division head of dermatology, Seattle Children's Hospital, University of Washington School of Medicine
Raj Chovatiya, MD, PhD, associate professor at the Rosalind Franklin University Chicago Medical School, founder and director of the Center for Medical Dermatology and Immunology Research
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.